O-Phenylhydroxylamine → HCID 75151422, compound
Reaction equation
[C:1]1([O:7][NH2:8])[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.[CH3:9][C:10]1[N:14]([CH2:15][C:16]([N:18]2[CH2:23][CH2:22][CH:21]([C:24]3[S:25][CH:26]=[C:27]([CH:29]=O)[N:28]=3)[CH2:20][CH2:19]2)=[O:17])[N:13]=[C:12]([C:31]([F:34])([F:33])[F:32])[CH:11]=1>C(O)C>[C:1]1([O:7][N:8]=[CH:29][C:27]2[N:28]=[C:24]([CH:21]3[CH2:20][CH2:19][N:18]([C:16](=[O:17])[CH2:15][N:14]4[C:10]([CH3:9])=[CH:11][C:12]([C:31]([F:32])([F:34])[F:33])=[N:13]4)[CH2:23][CH2:22]3)[S:25][CH:26]=2)[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
At room temperature, O-phenylhydroxylamine (41 mg) and Amberlyst A21 (200 mg) are added to a solution of 2-(1-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazole-4-carbaldehyde (100 mg) in ethanol. The reaction mixture is stirred at room temperature for 24 hours. The solvent is then removed under reduced pressure. The residue is purified by column chromatography (silica gel, ethyl acetate:hexane 0%-100% elution gradient). This gives 2-(1-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazole-4-carbaldehyde O-phenyl oxime (50 mg, 40%) which consists of an about 9:1 mixture of cis and trans isomers (log P(pH2.7)=3.74 (93%), 3.94 (7%)).
Workup
- customThe solvent is then removed under reduced pressure
- customThe residue is purified by column chromatography (silica gel, ethyl acetate:hexane 0%-100% elution gradient)
- additionabout 9:1 mixture of cis and trans isomers (log P(pH2.7)=3.74 (93%), 3.94 (7%))
Sources & evidence
- ORD record
- ord-24c4ccf1cf93479a8156a0dae26b4f6c
- Source dataset
- uspto-grants-2014_04
- Patent number
- US08697878B2
Reaction notes
Loading…